BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19897717)

  • 1. ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine.
    Stevens LA; Levine RL; Gochuico BR; Moss J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19796-800. PubMed ID: 19897717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1.
    Stevens LA; Barbieri JT; Piszczek G; Otuonye AN; Levine RL; Zheng G; Moss J
    J Immunol; 2014 Dec; 193(12):6144-51. PubMed ID: 25392530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP-ribosyltransferase-specific modification of human neutrophil peptide-1.
    Paone G; Stevens LA; Levine RL; Bourgeois C; Steagall WK; Gochuico BR; Moss J
    J Biol Chem; 2006 Jun; 281(25):17054-17060. PubMed ID: 16627471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mono-ADP-Ribosylation Catalyzed by Arginine-Specific ADP-Ribosyltransferases.
    Stevens LA; Moss J
    Methods Mol Biol; 2018; 1813():149-165. PubMed ID: 30097866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.
    Moss J; Zolkiewska A; Okazaki I
    Adv Exp Med Biol; 1997; 419():25-33. PubMed ID: 9193633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties.
    Paone G; Wada A; Stevens LA; Matin A; Hirayama T; Levine RL; Moss J
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8231-5. PubMed ID: 12060767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine-specific mono ADP-ribosylation in vitro of antimicrobial peptides by ADP-ribosylating toxins.
    Castagnini M; Picchianti M; Talluri E; Biagini M; Del Vecchio M; Di Procolo P; Norais N; Nardi-Dei V; Balducci E
    PLoS One; 2012; 7(8):e41417. PubMed ID: 22879887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling.
    Corda D; Di Girolamo M
    Sci STKE; 2002 Dec; 2002(163):pe53. PubMed ID: 12488509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylation of arginine.
    Laing S; Unger M; Koch-Nolte F; Haag F
    Amino Acids; 2011 Jul; 41(2):257-69. PubMed ID: 20652610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid specific ADP-ribosylation: substrate specificity of an ADP-ribosylarginine hydrolase from turkey erythrocytes.
    Moss J; Oppenheimer NJ; West RE; Stanley SJ
    Biochemistry; 1986 Sep; 25(19):5408-14. PubMed ID: 3778868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of arginine-ADP-ribosylated protein using recombinant ADP-ribosylarginine hydrolase.
    Ohno T; Tsuchiya M; Osago H; Hara N; Jidoi J; Shimoyama M
    Anal Biochem; 1995 Oct; 231(1):115-22. PubMed ID: 8678289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new detection method for arginine-specific ADP-ribosylation of protein -- a combinational use of anti-ADP-ribosylarginine antibody and ADP-ribosylarginine hydrolase.
    Osago H; Terashima M; Hara N; Yamada K; Tsuchiya M
    J Biochem Biophys Methods; 2008 Apr; 70(6):1014-9. PubMed ID: 18160133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas-Phase Fragmentation of ADP-Ribosylated Peptides: Arginine-Specific Side-Chain Losses and Their Implication in Database Searches.
    Gehrig PM; Nowak K; Panse C; Leutert M; Grossmann J; Schlapbach R; Hottiger MO
    J Am Soc Mass Spectrom; 2021 Jan; 32(1):157-168. PubMed ID: 33140951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ADP-ribosylation sites on desmin and restoration of desmin intermediate filament assembly by de-ADP-ribosylation .
    Zhou H; Huiatt TW; Robson RM; Sernett SW; Graves DJ
    Arch Biochem Biophys; 1996 Oct; 334(2):214-22. PubMed ID: 8900395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the identification of arginine ADP-ribosylation sites.
    Laing S; Koch-Nolte F; Haag F; Buck F
    J Proteomics; 2011 Dec; 75(1):169-76. PubMed ID: 21784185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes.
    Zolkiewska A; Moss J
    J Biol Chem; 1995 Apr; 270(16):9227-33. PubMed ID: 7721841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mammalian ADP-ribosylation cycles.
    Okazaki IJ; Zolkiewska A; Takada T; Moss J
    Biochimie; 1995; 77(5):319-25. PubMed ID: 8527484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of endogenous mono-ADP-ribosylation of cardiac proteins via anti-ADP-ribosylarginine immunoreactivity.
    Schwab CJ; Colville MJ; Fullerton AT; McMahon KK
    Proc Soc Exp Biol Med; 2000 Apr; 223(4):389-96. PubMed ID: 10721009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-L-arginine cleavage enzyme.
    Moss J; Jacobson MK; Stanley SJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5603-7. PubMed ID: 2994036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha 7 integrin as a target protein for cell surface mono-ADP-ribosylation in muscle cells.
    Zolkiewska A; Moss J
    Adv Exp Med Biol; 1997; 419():297-303. PubMed ID: 9193669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.